UBS lowered the price target on Salesforce, Inc. (NYSE:CRM) from $300 to $260 on August 18, maintaining a Neutral rating. Analyst Karl Keirstead cites challenges in expanding distribution capacity and slow integration of Informatica, signaling caution in CRM’s growth potential.
Emergent, a solutions provider for public sector technology strategies, incorporated Salesforce services and Agentforce solutions into its GSA contract on August 21. This move highlights the increasing demand for Salesforce’s Agentforce platform, which is gaining traction in the market.
Analyst Patrick Walravens from Citizens JMP rates Salesforce, Inc. (NYSE:CRM) as Outperform with a $430 price target. The company’s Q2 FY2025 results are set for September 3. As of August 25, Salesforce’s average price target of $350 suggests a 41.20% upside potential based on analysts’ estimates.
Salesforce, Inc. (NYSE:CRM) is a cloud-based CRM company renowned for its AI-powered platform, Agentforce. Despite its popularity, some AI stocks may offer better investment opportunities with greater upside potential and lower downside risks, especially in the current market conditions.
Read more at Yahoo Finance: UBS Lowers PT on Salesforce from $300 to $260, Keeps Neutral Rating on the Stock
